Yoichiro Hashimoto

Comparative effectiveness of atogepant and rimegepant for migraine prevention in Japanese patients: an anchored matching-adjusted indirect comparison.

Journal: Expert review of neurotherapeutics

Published: December 18, 2025

Feasibility and Safety of a Novel 4 Fr Sheath Transradial and Transbrachial Approach for Mechanical Thrombectomy in Selected Patients.

Journal: Neurologia medico-chirurgica

Published: November 03, 2025

Real-World Patent Foramen Ovale Closure in Japan　- Results From 1-Year Follow-up of the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: June 15, 2025

Stroke severity and prognosis in patients on the brink of end-stage chronic kidney disease: K-PLUS registry.

Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Published: May 07, 2025

Real-World Patent Foramen Ovale (PFO) Closure in Japan　- 30-Day Clinical Outcomes From the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: May 12, 2024

Stent-retriever characteristics and strategies associated with recanalization in thrombectomy for acute ischemic stroke.

Journal: Clinical neurology and neurosurgery

Published: February 08, 2024

Evidence and Recommendations for Acute Stroke Rehabilitation from the Japan Stroke Society: Abridged Secondary Publication of the Japanese-language Version.

Journal: Progress in rehabilitation medicine

Published: December 06, 2023

National trends in the outcomes of subarachnoid haemorrhage and the prognostic influence of stroke centre capability in Japan: retrospective cohort study.

Journal: BMJ open

Published: April 10, 2023

Subdural hematoma with reversible cerebral vasoconstriction syndrome: a case report

Journal: Rinsho shinkeigaku = Clinical neurology

Published: August 28, 2022

Impact of COVID-19 on the Volume of Acute Stroke Admissions: A Nationwide Survey in Japan.

Journal: Neurologia medico-chirurgica

Published: June 26, 2022

Lasmiditan for single migraine attack in Japanese patients with cardiovascular risk factors: subgroup analysis of a phase 2 randomized placebo-controlled trial.

Journal: Expert opinion on drug safety

Published: June 24, 2022

Long-Term Prevalence of Disaster-Related Deep Vein Thrombosis in Minamiaso Village After the 2016 Kumamoto Earthquakes: A Prospective Cross-Sectional Analysis.

Journal: Disaster medicine and public health preparedness

Published: November 19, 2021

Comparative effectiveness of atogepant and rimegepant for migraine prevention in Japanese patients: an anchored matching-adjusted indirect comparison.

Comparative effectiveness of atogepant and rimegepant for migraine prevention in Japanese patients: an anchored matching-adjusted indirect comparison.

Feasibility and Safety of a Novel 4 Fr Sheath Transradial and Transbrachial Approach for Mechanical Thrombectomy in Selected Patients.

Feasibility and Safety of a Novel 4 Fr Sheath Transradial and Transbrachial Approach for Mechanical Thrombectomy in Selected Patients.

Real-World Patent Foramen Ovale Closure in Japan - Results From 1-Year Follow-up of the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Real-World Patent Foramen Ovale Closure in Japan - Results From 1-Year Follow-up of the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Stroke severity and prognosis in patients on the brink of end-stage chronic kidney disease: K-PLUS registry.

Stroke severity and prognosis in patients on the brink of end-stage chronic kidney disease: K-PLUS registry.

Real-World Patent Foramen Ovale (PFO) Closure in Japan - 30-Day Clinical Outcomes From the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Real-World Patent Foramen Ovale (PFO) Closure in Japan - 30-Day Clinical Outcomes From the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Stent-retriever characteristics and strategies associated with recanalization in thrombectomy for acute ischemic stroke.

Stent-retriever characteristics and strategies associated with recanalization in thrombectomy for acute ischemic stroke.

Evidence and Recommendations for Acute Stroke Rehabilitation from the Japan Stroke Society: Abridged Secondary Publication of the Japanese-language Version.

Evidence and Recommendations for Acute Stroke Rehabilitation from the Japan Stroke Society: Abridged Secondary Publication of the Japanese-language Version.

National trends in the outcomes of subarachnoid haemorrhage and the prognostic influence of stroke centre capability in Japan: retrospective cohort study.

National trends in the outcomes of subarachnoid haemorrhage and the prognostic influence of stroke centre capability in Japan: retrospective cohort study.

Subdural hematoma with reversible cerebral vasoconstriction syndrome: a case report

Subdural hematoma with reversible cerebral vasoconstriction syndrome: a case report

Impact of COVID-19 on the Volume of Acute Stroke Admissions: A Nationwide Survey in Japan.

Impact of COVID-19 on the Volume of Acute Stroke Admissions: A Nationwide Survey in Japan.

Lasmiditan for single migraine attack in Japanese patients with cardiovascular risk factors: subgroup analysis of a phase 2 randomized placebo-controlled trial.

Lasmiditan for single migraine attack in Japanese patients with cardiovascular risk factors: subgroup analysis of a phase 2 randomized placebo-controlled trial.

Long-Term Prevalence of Disaster-Related Deep Vein Thrombosis in Minamiaso Village After the 2016 Kumamoto Earthquakes: A Prospective Cross-Sectional Analysis.

Long-Term Prevalence of Disaster-Related Deep Vein Thrombosis in Minamiaso Village After the 2016 Kumamoto Earthquakes: A Prospective Cross-Sectional Analysis.

Real-World Patent Foramen Ovale Closure in Japan　- Results From 1-Year Follow-up of the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Real-World Patent Foramen Ovale Closure in Japan　- Results From 1-Year Follow-up of the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Real-World Patent Foramen Ovale (PFO) Closure in Japan　- 30-Day Clinical Outcomes From the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Real-World Patent Foramen Ovale (PFO) Closure in Japan　- 30-Day Clinical Outcomes From the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.